Reckon Limited (ASX: RKN) announces leadership changes

Reckon Limited (ASX: RKN) prepares for the future with a change in leadership

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Reckon Limited (ASX: RKN), the accounting software company, has announced leadership changes with its long-serving Chairman Ian Ferrier retiring effective 1 July 2018.

The current Group CEO Clive Rabie will step aside from day to day operations and hand over to a new CEO, Sam Allert, who is currently running Reckon's Australia and New Zealand operations.

Mr Rabie's new role will be to act as Managing Director, "allowing him to focus on corporate strategy and mergers and acquisitions while mentoring and overseeing the executive team during a transition period of about 2 years" the announcement said.

Shares in Reckon soared 33% in November last year when a potential $180 million sale of Reckon's accountant group to Myob Group Ltd (ASX: MYO) was announced.

They have since lost all those gains and are now down 37% from their November 2017 high after Myob pulled away from the deal following indications that the ACCC would not approve the merger.

What now?

With the Myob deal off the table, Reckon shareholders might be cheered by Mr Rabie's new mandate to focus on mergers and acquisitions.

There is a view that Reckon doesn't have the resources to invest in its Accountant Group which is why a sale to a bigger player would be preferable.

With cash on hand as at the last reporting date (31 December 2017) of $2m, almost 4 times the amount of debt to equity and a balance sheet dominated largely by intangible assets, that view has some merit.

Focus on users 

Investors will now want to monitor whether Reckon can maintain or grow its user base. There is a risk that some users may transition to Myob or fast-growing competitor Xero Limited (ASX: XRO).

While Reckon isn't on my buy list, our team of experts have identified these four companies as the best shares to buy right now.

Motley Fool contributor Kevin Gandiya has no position in any of the stocks mentioned. You can find Kevin on Twitter @KevinGandiya. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »